Let's Talk

Innovating at the Intersection of Life Sciences and Strategy

At the forefront of biotechnology, pharmaceuticals, and medical innovation, Stratford's Life Sciences Intellectual Property Practice Group delivers strategic, end-to-end IP advice tailored to the unique challenges of the life sciences sector.

Whether protecting a groundbreaking molecule, medical device, or AI application in life sciences, we combine deep sectoral knowledge with global IP insight to ensure our clients’ innovations remain protected and commercially viable across jurisdictions.

Driving Commercial Value Through Strong IP Foundations

We partner with early-stage and scale-up biotech firms, academic spinouts, multinational pharmaceutical companies, and medical device innovators to transform scientific discovery into defensible IP portfolios.

  • Biotech Startups
  • Academic Spinouts 
  • Mutlinational Pharma 
  • Medtech Innovators
Schedule Your Free Strategy Session

End-to-End IP Strategies for Growth and Protection

Our team excels in developing comprehensive protection strategies, leveraging intellectual property rights and intangible assets to support our clients through the IP lifecycle.
1 (2)

Draft and Prosecute to Embody Innovation

We translate your inventions and brands into strategically crafted patent and trademark applications ensuring strong, enforceable protection across key jurisdictions.
2-1

Manage and Scale Global IP Portfolios

From initial filings to worldwide coordination, we oversee your IP assets with precision maintaining alignment with your growth, compliance, and commercialization goals.
3-1

Navigate Risk and Unlock Intelligence

We conduct freedom-to-operate assessments, analyze third-party rights, and extract actionable business insights from the IP landscape to reduce exposure and uncover opportunity.
4-1

Build Valuation-Ready IP Frameworks

Our IP strategists create holistic protection strategies that support fundraising, licensing, and exit ensuring your portfolio drives real commercial and investor value.

Your Strategic Partner for Growth, Licensing, and Investment

From the lab bench to the boardroom, our IP professionals understand the nuances of life sciences transactions. We routinely advise on IP due diligence, cross-border licensing agreements, collaboration arrangements, and investor-facing IP audits.


Whether you're raising capital, entering into a co-development partnership, or preparing for acquisition, our team provides the clarity and foresight needed to position your IP portfolio as a catalyst for growth and long-term value creation.

Real Results from Life Sciences Leaders Like You

“We have been working with the team at Stratford for several months as a VIP Strategic Solutions client and we have been very happy with how they are handling our IP portfolio and overall strategy. It is rare to find an IP firm that approaches IP management so holistically.

 
At the outset, Stratford took the time to listen and understand our business goals and long-term plans, so that their IP recommendations align with our overall corporate objectives. Stratford also assisted us in formalizing internal processes to ensure that inventions are disclosed, catalogued, and filed promptly and properly.
 
We are confident in both our IP strategy and that our day-to-day matters are being diligently managed. Stratford ensured that our innovation and technology is protected and that nothing is missed. We know that we are in good hands."

FluidAI colour logo

Ricky Tjandra

Director of Research

Make Informed IP Decisions with Confidence

Book a Complimentary Strategy Call or Ask a Question

Let’s protect and elevate your innovation with a solution that truly fits your scientific and commercial goals. Whether you're navigating global filings, preparing for funding, or evaluating IP strategy options, our team is here to help. Fill out the form, and we’ll connect with you to explore next steps — no pressure, just clarity.